Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMLET: E2 Patch/Antagonist vs OCP/Microdose Lupron in Poor Responder IVF
NCT00826839Phase 4Withdrawn
- Sponsor
- Weill Cornell Medicine
- Start
- Jan 2009
- Primary completion
- Sep 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of estradiol topical, ganirelix in infertility, sponsored by Weill Cornell Medicine. Planned start Jan 2009; status: withdrawn.
02
Drugs
estradiol topicalganirelix
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00826839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00826839.